Changeflow GovPing Healthcare & Life Sciences Polyproline Nanocage Compound and Manufacturing...
Routine Notice Added Final

Polyproline Nanocage Compound and Manufacturing Method

Email

Summary

The USPTO has published a patent application for a polyproline nanocage compound and its manufacturing method. The application details a compound comprising two cyclic peptide scaffolds connected by molecules, with each scaffold containing polyproline helix rods and turn-angle molecules. This is a routine publication of a new patent application.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application (US20260085133A1) filed with the USPTO. It describes a novel polyproline nanocage compound composed of cyclic peptide scaffolds and connecting molecules, detailing the structural components including polyproline helix rods and turn-angle molecules. The application was filed on September 24, 2025.

As this is a patent application publication, it does not impose any new regulatory obligations or compliance deadlines on regulated entities. It serves as a notice of potential intellectual property and may be of interest to companies involved in peptide research, drug development, or biomaterials manufacturing. Compliance officers should note this as a development in the intellectual property landscape within the biotechnology and pharmaceutical sectors.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

POLYPROLINE NANOCAGE COMPOUND AND MANUFACTURING METHOD THEREOF

Application US20260085133A1 Kind: A1 Mar 26, 2026

Inventors

Sheng-Kai WANG, Chia-Lung TSAI, Yi-Cheng HSU, Hsiao-Ling CHIU, Tzu-Yuan CHEN

Abstract

A polyproline nanocage compound includes two cyclic peptide scaffolds and at least three connecting molecules. The two cyclic peptide scaffolds include at least three polyproline helix rods and at least three turn-angle molecules. Each of the at least three polyproline helix rods is composed of a plurality of repeat units. Two of the at least three polyproline helix rods are connected by one of the at least three turn-angle molecules so as to form a closed ring. The at least three connecting molecules are respectively connected from the at least three polyproline helix rods of one of the two cyclic peptide scaffolds to the at least three polyproline helix rods of the other of the two cyclic peptide scaffolds.

CPC Classifications

C07K 19/00 C07K 14/001

Filing Date

2025-09-24

Application No.

19338380

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260085133A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Biotechnology Research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!